After NSCEB: What Comes Next for U.S. Biotech Policy
Organized by STATION DC and the National Security Commission on Emerging Biotechnology
An afternoon event co-hosted by STATION DC and the National Security Commission on Emerging Biotechnology, whose authority expires at the end of 2026. Lawmakers, founders and investors will discuss who carries the commission's biotech policy work into 2027. The agenda is still to be announced, and registrations are approved on a rolling basis.